SYNTHESIS OF (+/-)-TRANS-6-[4,4-BIS(4-FLUOROPHENYL)-3-(1-METHYL-1H-TETRAZOL-5-YL)-1(E),3-[2-C-14]BUTADIENYL]-4-HYDROXY-3,4,5,6-TETRAHYDRO-2H-PYRAN-2-ONE

被引：1
|
作者：
LUKE, GM
SWIGOR, JE
机构：
[1] Bristol-Myers Squibb, Pharmaceutical Research and Development Division, Syracuse, New York
来源：
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS | 1991年 / 29卷 / 02期
关键词：
(+/-)-TRANS-6-[4,4-BIS(4-FLUOROPHENYL)-3-(1-METHYL-1H-TETRAZOL-5-YL)-1(E),3-[2-; HMG-COA REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC;
D O I：
10.1002/jlcr.2580290209
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
A convergent synthesis of the title compound (BMY-22089) is described. [C-14]Methyl iodide was used to alkylate 1,5-dimethyltetrazole which was added to 4,4'-difluorobenzophenone to give the tertiary alcohol 4. Dehydration gave the olefin 5 which was brominated and converted to the phosphonate 7 with trimethylphosphite. Coupling of the carbanion of 7 with cis-2, 2-dimethyl-6-formyl-1,3-dioxane-4-acetic acid tert-butyl ester (8) produced the diene 9. Sequential hydrolysis steps using acid and base gave the dihydroxy acid 11 which was converted to the lactone 12 with the use of dicyclohexylcarbodiimide. The overall yield was 20%.
引用
收藏
页码：193 / 199
页数：7
相关论文
共 50 条
  • [1] ENANTIOSELECTIVE ENZYMATIC ACETYLATION OF RACEMIC [4-[4-ALPHA,6-BETA (E)]]-6-[4,4-BIS(4-FLUOROPHENYL)-3-(1-METHYL-1H-TETRAZOL-5-YL)-1,3-BUTADIENYL]-TETRAHYDRO-4-HYDROXY-2H-PYRAN-2-ONE
    PATEL, RN
    MCNAMEE, CM
    SZARKA, LJ
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 1992, 38 (01) : 56 - 60
  • [2] (E)-1-(1-Benzyl-5-methyl-1H-1,2,3-triazol-4-yl)-3-(4-fluorophenyl)prop-2-en-1-one
    Fun, Hoong-Kun
    Hemamalini, Madhukar
    Shanmugavelan, Poovan
    Ponnuswamy, Alagusundaram
    Jagatheesan, Rathinavel
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O2776 - +
  • [3] 3-(4-fluorophenyl)-1-methyl-4-(4-pyridyl)quinolin-2(1H)-one
    Peifer, Christian
    Schollmeyer, Dieter
    Kinkel, Katrin
    Laufer, Stefan
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2007, 63 : O2457 - O2459
  • [4] 3-(2H-Benzotriazol-2-yl)-1-(4-fluorophenyl)propan-1-one
    Pan, Zhi-Fang
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2010, 66 : O1124 - U529
  • [5] Synthesis and Structural Characterization of Isostructural 4-(4-Aryl)-2-(5-(4-fluorophenyl)-3-(1-(4-fluorophenyl)-5-methyl-1H-1,2,3-triazol-4-yl)-4,5-dihydro-1H-pyrazol-1-yl)thiazoles
    Kariuki, Benson M.
    Abdel-Wahab, Bakr F.
    El-Hiti, Gamal A.
    CRYSTALS, 2021, 11 (07)
  • [6] (2E)-3-(4-Fluorophenyl)-1-[5-methyl-1-(4-methylphenyl)-1H-1,2,3-triazol-4-yl]prop-2-en-1-one
    Abdel-Wahab, Bakr F.
    Mohamed, Hanan A.
    Ng, Seik Weng
    Tiekink, Edward R. T.
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2013, 69 : O638 - +
  • [7] 3-(4-fluorophenyl)-1-[1′-(4-fluorophenyl)2-oxo-5′,6′,7′,7a′-tetrahydro-1H-indole-3(2H)-spiro-3′(2′H)-1H′-pyrrolizin-2′-yl]prop-2-en-1-one
    Nirmala, S.
    Murugan, R.
    Kamala, E. Theboral Sugi
    Sudha, L.
    Narayanan, S. Sriman
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2008, 64 : O1774 - U2105
  • [8] INHIBITORS OF HMG-COA REDUCTASE - BIOLOGICAL EFFECTS OF A 6-[2-[2-(4-FLUORO-3-METHYLPHENYL)-4-SUBSTITUTED CYCLOHEX-1-EN-1-YL]ETHENYL]-4-HYDROXY-3,4,5,6-TETRAHYDRO-2H-PYRAN-2-ONE
    REGAN, JR
    BRUNO, JG
    GUSTAFSON, K
    AMIN, D
    NEUENSCHWANDER, K
    PERRONE, M
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1992, 27 (07) : 735 - 742
  • [9] (2E)-1-(4,4"-Difluoro-5′-methoxy-1,1′:3′, 1"-terphenyl-4′-yl)-3-(4-fluorophenyl)prop-2-en-1-one
    Betz, Richard
    Gerber, Thomas
    Hosten, Eric
    Samshuddin, S.
    Narayana, Badiadka
    Sarojini, Balladka K.
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O2996 - U1054
  • [10] Synthesis of 4,4'-Bis[3-(Fluorodinitromethyl)-1H-1,2,4-triazol-5-Yl]azofurazan
    Aleksandrova, Nataly S.
    Monogarov, Konstantin A.
    Sheremetev, Aleksei B.
    CHEMISTRY OF HETEROCYCLIC COMPOUNDS, 2020, 56 (05) : 619 - 622
12345